News
DGAP-Adhoc: Allgeier SE shows significant revenue and earnings growth in the first half of 2022 and confirms guidance for 2022
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Biomind Labs Appoints Former FDA Director Dr. Thomas Laughren as Medical Advisor for Clinical Trials
Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
T-Mobile Delivers Industry-Leading Postpaid Service Revenue and Cash Flow Growth in Q2 2022 and Raises Guidance Across the Board
T-Mobile US, Inc. (NASDAQ: TMUS):
Industry-Leading Growth in Postpaid and Broadband Customers(1)
-
Postpaid net account additions of 380 thousand, best in industry and highest in company history
Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies
AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused
Fresh Del Monte Produce Inc. to Report Second Quarter 2022 Financial Results
Fresh Del Monte Produce Inc. (NYSE: FDP), today announced that it will issue a press release on its second quarter 2022 financial results prior to the market opening on Wednesday, August 3, 2022
DGAP-News: Varengold Bank AG significantly increases key figures in the first half of 2022
U.K. Firms Transform Networks for Competitive Edge
Enterprises in the U.K. are treating networks less as a commodity and more as a strategic asset since the COVID-19 pandemic disrupted work modes and many industries, according to a new research
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Genel Energy PLC: Changes to Director’s Responsibilities
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
DGAP-Adhoc: bet-at-home.com AG: bet-at-home.com Group will outsource key corporate functions
DGAP-Adhoc: Varengold Bank AG raises profit forecast by 50 % for the 2022 financial year
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a series of enhancements for its QIAcuity series of digital PCR (dPCR) instruments designed to drive greater use among customers